Zevenbergen Capital Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-74,197
| Closed | -$25.6M | – | 85 |
|
|
2018
Q2 | $25.6M | Sell |
74,197
-49,850
| -40% | -$17.2M | 0.85% | 36 |
|
|
2018
Q1 | $42.7M | Sell |
124,047
-5,618
| -4% | -$1.93M | 1.64% | 25 |
|
|
2017
Q4 | $48.7M | Sell |
129,665
-13,020
| -9% | -$4.9M | 2.03% | 21 |
|
|
2017
Q3 | $63.8M | Sell |
142,685
-3,925
| -3% | -$1.75M | 2.77% | 14 |
|
|
2017
Q2 | $72M | Sell |
146,610
-4,130
| -3% | -$2.03M | 3.13% | 13 |
|
|
2017
Q1 | $58.4M | Buy |
150,740
+4,764
| +3% | +$1.85M | 2.69% | 14 |
|
|
2016
Q4 | $53.6M | Sell |
145,976
-16,447
| -10% | -$6.04M | 2.52% | 15 |
|
|
2016
Q3 | $65.3M | Buy |
162,423
+1,445
| +0.9% | +$581K | 2.68% | 14 |
|
|
2016
Q2 | $56.2M | Buy |
160,978
+17,342
| +12% | +$6.06M | 2.63% | 14 |
|
|
2016
Q1 | $51.8M | Buy |
143,636
+12,825
| +10% | +$4.62M | 2.34% | 16 |
|
|
2015
Q4 | $71M | Buy |
130,811
+18,420
| +16% | +$10M | 2.89% | 10 |
|
|
2015
Q3 | $52.3M | Sell |
112,391
-40
| -0% | -$18.6K | 2.24% | 20 |
|
|
2015
Q2 | $57.4M | Buy |
112,431
+335
| +0.3% | +$171K | 2.23% | 21 |
|
|
2015
Q1 | $50.6M | Buy |
112,096
+104,836
| +1,444% | +$47.3M | 2.12% | 22 |
|
|
2014
Q4 | $2.98M | Buy |
+7,260
| New | +$2.98M | 0.13% | 41 |
|